About ethyl 2-[(2R)-3-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-2-(1H-indole-2-carbonylamino)-3-oxopropyl]sulfanylpyridine-3-carboxylate
ethyl 2-[(2R)-3-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-2-(1H-indole-2-carbonylamino)-3-oxopropyl]sulfanylpyridine-3-carboxylate (PubChem CID 67640657) has the molecular formula C37H35F2N5O4S
and a molecular weight of 683.78 g/mol. Its IUPAC name is ethyl 2-[(2R)-3-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-2-(1H-indole-2-carbonylamino)-3-oxopropyl]sulfanylpyridine-3-carboxylate.
Molecular Properties
| Compound Name | ethyl 2-[(2R)-3-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-2-(1H-indole-2-carbonylamino)-3-oxopropyl]sulfanylpyridine-3-carboxylate |
| PubChem CID | 67640657 |
| Molecular Formula | C37H35F2N5O4S |
| Molecular Weight | 683.78 g/mol |
| Exact Mass | 683.24 |
| IUPAC Name | ethyl 2-[(2R)-3-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-2-(1H-indole-2-carbonylamino)-3-oxopropyl]sulfanylpyridine-3-carboxylate |
| SMILES | CCOC(=O)c1cccnc1SC[C@H](NC(=O)c1cc2ccccc2[nH]1)C(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1 |
| InChI | InChI=1S/C37H35F2N5O4S/c1-2-48-37(47)29-7-5-17-40-35(29)49-23-32(42-34(45)31-22-26-6-3-4-8-30(26)41-31)36(46)44-20-18-43(19-21-44)33(24-9-13-27(38)14-10-24)25-11-15-28(39)16-12-25/h3-17,22,32-33,41H,2,18-21,23H2,1H3,(H,42,45)/t32-/m0/s1 |
| InChIKey | UELPNYQVIUKPEJ-YTTGMZPUSA-N |
| XLogP | 5.84 |
| TPSA | 107.63 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 49 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 683.78 |
| LogP ≤ 5 | 5.84 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Analyze ethyl 2-[(2R)-3-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-2-(1H-indole-2-carbonylamino)-3-oxopropyl]sulfanylpyridine-3-carboxylate with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of ethyl 2-[(2R)-3-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-2-(1H-indole-2-carbonylamino)-3-oxopropyl]sulfanylpyridine-3-carboxylate?
The IUPAC name of ethyl 2-[(2R)-3-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-2-(1H-indole-2-carbonylamino)-3-oxopropyl]sulfanylpyridine-3-carboxylate (CID 67640657) is ethyl 2-[(2R)-3-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-2-(1H-indole-2-carbonylamino)-3-oxopropyl]sulfanylpyridine-3-carboxylate.
What is the SMILES notation for ethyl 2-[(2R)-3-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-2-(1H-indole-2-carbonylamino)-3-oxopropyl]sulfanylpyridine-3-carboxylate?
The canonical SMILES for ethyl 2-[(2R)-3-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-2-(1H-indole-2-carbonylamino)-3-oxopropyl]sulfanylpyridine-3-carboxylate is CCOC(=O)c1cccnc1SC[C@H](NC(=O)c1cc2ccccc2[nH]1)C(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1.
What is the InChIKey of ethyl 2-[(2R)-3-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-2-(1H-indole-2-carbonylamino)-3-oxopropyl]sulfanylpyridine-3-carboxylate?
The InChIKey is UELPNYQVIUKPEJ-YTTGMZPUSA-N. The full InChI is InChI=1S/C37H35F2N5O4S/c1-2-48-37(47)29-7-5-17-40-35(29)49-23-32(42-34(45)31-22-26-6-3-4-8-30(26)41-31)36(46)44-20-18-43(19-21-44)33(24-9-13-27(38)14-10-24)25-11-15-28(39)16-12-25/h3-17,22,32-33,41H,2,18-21,23H2,1H3,(H,42,45)/t32-/m0/s1.
What are the key properties of ethyl 2-[(2R)-3-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-2-(1H-indole-2-carbonylamino)-3-oxopropyl]sulfanylpyridine-3-carboxylate?
ethyl 2-[(2R)-3-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-2-(1H-indole-2-carbonylamino)-3-oxopropyl]sulfanylpyridine-3-carboxylate has a molecular weight of 683.78 g/mol, XLogP of 5.84, 11 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for ethyl 2-[(2R)-3-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-2-(1H-indole-2-carbonylamino)-3-oxopropyl]sulfanylpyridine-3-carboxylate is sourced from PubChem (CID 67640657), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).